Global Buprenorphine Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 158912
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 115
  • list Pharmaceuticals and Healthcare

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.

Scope of the Report:

This report focuses on the Buprenorphine Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

USA is the dominate consumer in buprenorphine hydrochloride industry. The sales volume of USA was 5312 kg in 2015, occupied about 48.11% of the total amount. Europe is the second one, with the sales volume of 4222 kg, and the sales market share of 38.24% in 2015.

The worldwide market for Buprenorphine Hydrochloride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Siegfried

Sanofi

Johnson Matthey

Mallinckrodt

Noramco

Unichemlabs

Arevipharma

Resonance-labs

Sun Pharma

Rusan Pharma

Micro Orgo Chem

Faranshimi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type I

Type II

Market Segment by Applications, can be divided into

Analgesic

Opioid Antagonist

There are 15 Chapters to deeply display the global Buprenorphine Hydrochloride market.

Chapter 1, to describe Buprenorphine Hydrochloride Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Buprenorphine Hydrochloride, with sales, revenue, and price of Buprenorphine Hydrochloride, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Buprenorphine Hydrochloride, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Buprenorphine Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Buprenorphine Hydrochloride sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Buprenorphine Hydrochloride Introduction

1.2 Market Analysis by Type

1.2.1 Type I

1.2.2 Type II

1.3 Market Analysis by Applications

1.3.1 Analgesic

1.3.2 Opioid Antagonist

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Siegfried

2.1.1 Business Overview

2.1.2 Buprenorphine Hydrochloride Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Siegfried Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi

2.2.1 Business Overview

2.2.2 Buprenorphine Hydrochloride Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson Matthey

2.3.1 Business Overview

2.3.2 Buprenorphine Hydrochloride Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Mallinckrodt

2.4.1 Business Overview

2.4.2 Buprenorphine Hydrochloride Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Noramco

2.5.1 Business Overview

2.5.2 Buprenorphine Hydrochloride Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Noramco Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Unichemlabs

2.6.1 Business Overview

2.6.2 Buprenorphine Hydrochloride Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Arevipharma

2.7.1 Business Overview

2.7.2 Buprenorphine Hydrochloride Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Resonance-labs

2.8.1 Business Overview

2.8.2 Buprenorphine Hydrochloride Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sun Pharma

2.9.1 Business Overview

2.9.2 Buprenorphine Hydrochloride Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Rusan Pharma

2.10.1 Business Overview

2.10.2 Buprenorphine Hydrochloride Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Micro Orgo Chem

2.11.1 Business Overview

2.11.2 Buprenorphine Hydrochloride Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Faranshimi

2.12.1 Business Overview

2.12.2 Buprenorphine Hydrochloride Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Buprenorphine Hydrochloride Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Buprenorphine Hydrochloride Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Buprenorphine Hydrochloride Manufacturer Market Share in 2017

3.3.2 Top 6 Buprenorphine Hydrochloride Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Buprenorphine Hydrochloride Market Analysis by Regions

4.1 Global Buprenorphine Hydrochloride Sales, Revenue and Market Share by Regions

4.1.1 Global Buprenorphine Hydrochloride Sales and Market Share by Regions (2013-2018)

4.1.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Regions (2013-2018)

4.2 North America Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

4.3 Europe Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

4.5 South America Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

5 North America Buprenorphine Hydrochloride by Countries

5.1 North America Buprenorphine Hydrochloride Sales, Revenue and Market Share by Countries

5.1.1 North America Buprenorphine Hydrochloride Sales and Market Share by Countries (2013-2018)

5.1.2 North America Buprenorphine Hydrochloride Revenue and Market Share by Countries (2013-2018)

5.2 United States Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

5.3 Canada Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

5.4 Mexico Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

6 Europe Buprenorphine Hydrochloride by Countries

6.1 Europe Buprenorphine Hydrochloride Sales, Revenue and Market Share by Countries

6.1.1 Europe Buprenorphine Hydrochloride Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Buprenorphine Hydrochloride Revenue and Market Share by Countries (2013-2018)

6.2 Germany Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

6.3 UK Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

6.4 France Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

6.5 Russia Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

6.6 Italy Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

7 Asia-Pacific Buprenorphine Hydrochloride by Countries

7.1 Asia-Pacific Buprenorphine Hydrochloride Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Buprenorphine Hydrochloride Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Buprenorphine Hydrochloride Revenue and Market Share by Countries (2013-2018)

7.2 China Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

7.3 Japan Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

7.4 Korea Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

7.5 India Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

8 South America Buprenorphine Hydrochloride by Countries

8.1 South America Buprenorphine Hydrochloride Sales, Revenue and Market Share by Countries

8.1.1 South America Buprenorphine Hydrochloride Sales and Market Share by Countries (2013-2018)

8.1.2 South America Buprenorphine Hydrochloride Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

8.3 Argentina Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

8.4 Colombia Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

9 Middle East and Africa Buprenorphine Hydrochloride by Countries

9.1 Middle East and Africa Buprenorphine Hydrochloride Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Buprenorphine Hydrochloride Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Buprenorphine Hydrochloride Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

9.3 UAE Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

9.4 Egypt Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

9.5 Nigeria Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

9.6 South Africa Buprenorphine Hydrochloride Sales and Growth Rate (2013-2018)

10 Global Buprenorphine Hydrochloride Market Segment by Type

10.1 Global Buprenorphine Hydrochloride Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Buprenorphine Hydrochloride Sales and Market Share by Type (2013-2018)

10.1.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Type (2013-2018)

10.2 Type I Sales Growth and Price

10.2.1 Global Type I Sales Growth (2013-2018)

10.2.2 Global Type I Price (2013-2018)

10.3 Type II Sales Growth and Price

10.3.1 Global Type II Sales Growth (2013-2018)

10.3.2 Global Type II Price (2013-2018)

11 Global Buprenorphine Hydrochloride Market Segment by Application

11.1 Global Buprenorphine Hydrochloride Sales Market Share by Application (2013-2018)

11.2 Analgesic Sales Growth (2013-2018)

11.3 Opioid Antagonist Sales Growth (2013-2018)

12 Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.1 Global Buprenorphine Hydrochloride Sales, Revenue and Growth Rate (2018-2023)

12.2 Buprenorphine Hydrochloride Market Forecast by Regions (2018-2023)

12.2.1 North America Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.2.2 Europe Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.2.3 Asia-Pacific Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.2.4 South America Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.2.5 Middle East and Africa Buprenorphine Hydrochloride Market Forecast (2018-2023)

12.3 Buprenorphine Hydrochloride Market Forecast by Type (2018-2023)

12.3.1 Global Buprenorphine Hydrochloride Sales Forecast by Type (2018-2023)

12.3.2 Global Buprenorphine Hydrochloride Market Share Forecast by Type (2018-2023)

12.4 Buprenorphine Hydrochloride Market Forecast by Application (2018-2023)

12.4.1 Global Buprenorphine Hydrochloride Sales Forecast by Application (2018-2023)

12.4.2 Global Buprenorphine Hydrochloride Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Buprenorphine Hydrochloride Picture

Table Product Specifications of Buprenorphine Hydrochloride

Figure Global Sales Market Share of Buprenorphine Hydrochloride by Ty

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery